---
id: 190
title: Procalcitonin (PCT) in Infectious Diseases
category: diagnostics
subcategory: laboratory
tags: [procalcitonin, PCT, biomarker, sepsis, antibiotic-stewardship, bacterial-vs-viral]
difficulty: medium
---

## Question

How is procalcitonin used clinically? Use **"Bacterial Infection = ↑PCT, Viral/Noninfectious = Low PCT → Guide Antibiotic Duration"** framework.

## Answer

### **Procalcitonin (PCT) Overview:**

**What It Is:**
- **Prohormone** of calcitonin (normally produced by thyroid C cells)
- **Elevated** in bacterial infections, sepsis (produced by extrathyroidal tissues in response to bacterial toxins, cytokines)

**Interpretation:**

| PCT Level | Interpretation |
|-----------|----------------|
| **<0.1 ng/mL** | **Low** - bacterial infection unlikely |
| **0.1-0.25 ng/mL** | **Low-moderate** - local bacterial infection possible |
| **0.25-0.5 ng/mL** | **Moderate** - bacterial infection likely, systemic involvement possible |
| **>0.5 ng/mL** | **High** - bacterial infection likely, sepsis possible |
| **>2 ng/mL** | **Very high** - severe bacterial infection/sepsis, high risk |
| **>10 ng/mL** | **Severe sepsis/septic shock** |

### **Clinical Uses:**

**1. Differentiate Bacterial vs. Viral/Noninfectious:**
- **Bacterial pneumonia:** PCT typically >0.25 ng/mL (often >0.5 ng/mL)
- **Viral respiratory infection:** PCT usually <0.25 ng/mL
- **Noninfectious inflammation:** PCT usually low (autoimmune, graft rejection)

**2. Guide Antibiotic Initiation:**
- **Lower respiratory tract infection (LRTI):**
  - **PCT <0.25 ng/mL:** Consider withholding antibiotics (likely viral)
  - **PCT ≥0.25 ng/mL:** Bacterial etiology more likely, initiate antibiotics

**3. Guide Antibiotic Duration:**
- **Monitor PCT levels** during treatment
- **Stop antibiotics when:**
  - **PCT drops <0.25 ng/mL** OR
  - **PCT drops by ≥80%** from peak
- **Reduces antibiotic duration** without increasing mortality

**4. Prognostic Marker in Sepsis:**
- **High PCT (>2 ng/mL):** Higher mortality risk
- **Rising PCT:** Worsening infection, treatment failure
- **Decreasing PCT:** Appropriate response to treatment

### **Evidence-Based Applications:**

**Community-Acquired Pneumonia (CAP):**
- **PCT-guided therapy reduces antibiotic duration** (typically 5 vs. 7-10 days)
- **Algorithms:**
  - Start antibiotics if PCT >0.25 ng/mL
  - Stop if PCT <0.25 ng/mL or 80% drop from peak

**COPD Exacerbation:**
- **PCT <0.1 ng/mL:** Withhold antibiotics (likely nonbacterial trigger)
- **PCT ≥0.25 ng/mL:** Initiate antibiotics

**Sepsis/ICU:**
- **PCT-guided discontinuation:** Stop antibiotics when PCT <0.5 ng/mL or 80% drop
- **Shorter antibiotic courses** (7 vs. 10-14 days)

### **Limitations:**

**False Elevations (Non-Bacterial):**
- **Severe trauma, surgery, burns** (first 24-48h)
- **Cardiogenic shock, severe pancreatitis**
- **Small cell lung cancer, medullary thyroid cancer** (rare)
- **Renal failure** (impaired clearance, mild elevation)

**False Negatives (Low Despite Bacterial Infection):**
- **Localized infection** (abscess, empyema without bacteremia)
- **Early infection** (<6h after symptom onset)
- **Immunosuppressed** (blunted response)
- **Atypical bacteria** (*Mycoplasma*, *Chlamydia*, *Legionella*) - lower PCT than typical bacterial

**Does NOT Differentiate:**
- **Gram-positive vs. Gram-negative**
- **Specific bacterial pathogen**

### **Comparison to Other Biomarkers:**

**PCT vs. CRP (C-Reactive Protein):**
- **PCT:** More specific for bacterial infection, rises/falls faster (6-24h)
- **CRP:** Less specific (elevated in bacterial, viral, noninfectious inflammation), slower (24-48h)

**PCT vs. WBC:**
- **PCT:** More specific, better for distinguishing bacterial vs. viral
- **WBC:** Less specific, many non-infectious causes

## Key Points

### **PCT for Antibiotic Stewardship:**
- **Primary use:** Guide antibiotic **duration** (stop when <0.25 or 80% drop)
- **Reduces antibiotic exposure** without increasing mortality
- **Best evidence:** CAP, COPD exacerbations, sepsis/ICU

### **Thresholds:**
- **<0.1 ng/mL:** Bacterial infection unlikely
- **0.25-0.5 ng/mL:** Bacterial infection likely
- **>0.5 ng/mL:** Systemic bacterial infection/sepsis likely
- **>2 ng/mL:** Severe sepsis, high mortality risk

### **Kinetics:**
- **Rises:** 6-12h after bacterial exposure (peaks 24-48h)
- **Falls:** Half-life ~24h (drops 50%/day if infection controlled)

### **NOT a Standalone Test:**
- **Use with clinical context** (history, exam, imaging, cultures)
- **Do NOT rely solely on PCT** to diagnose or exclude infection

### **Clinical Pearls:**
- **PCT <0.25 ng/mL:** Consider withholding antibiotics (likely viral) in LRTI
- **PCT >0.5 ng/mL:** Bacterial infection/sepsis likely
- **PCT-guided discontinuation:** Stop when <0.25 ng/mL or 80% drop from peak
- **Reduces antibiotic duration** in CAP, sepsis (evidence-based)
- **False elevations:** Trauma, surgery, burns (first 48h), cardiogenic shock

## Sources

- [IDSA: Procalcitonin in CAP/Sepsis 2024]
- [Chest: PCT-Guided Antibiotic Therapy Meta-Analysis 2024]

## Media

N/A
